Dihydroergotamine protects against ischemic stroke by modulating microglial/macrophage polarization and inhibiting inflammation in mice

CONCLUSION: This study is the first to demonstrate the protective effect of dihydroergotamine, a first-line treatment for migraine, against ischemic nerve injury in vitro and in vivo.PMID:38468466 | DOI:10.1080/01616412.2024.2328481

Source: Neurological Research - March 12, 2024 Category: Neurology Authors: Yangmin Zheng Yue Hu Feng Yan Rongliang Wang Zhen Tao Junfen Fan Ziping Han Haiping Zhao Ping Liu Wei Zhuang Yumin Luo Source Type: research